ArticleFrontiers in endocrinology2026
Assessment of bone density and microarchitecture in patients with familial partial lipodystrophy.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Familial partial lipodystrophy (FPL) is a rare condition related to partial deficiency of adipose tissue and consequent insulin resistance resulting in metabolic alterations. Although type 2 diabetes mellitus is associated with bone changes, few studies have evaluated bone health in familial partial lipodystrophy. Methods: Cross-sectional study that selected patients from a specific outpatient clinic for LPF and controls from a database of healthy individuals. Patients and controls underwent clinical evaluation and examinations by dual energy X-ray absorptiometry (DXA) and high-resolution quantitative peripheral computed tomography (HR-pQCT). Results: Twenty-four patients were included, with a mean age of 43.4 years (± 11.9), as twenty controls, with a mean age of 39.4 (± 6.4). In the FPL group, 15 participants had a diagnosis of DM, with a mean disease duration of 16.5 years (± 7.4). Regarding DXA, there was a statistical difference in the Z-score of the spine and femur, with higher values in the FPL group. Evaluating HR-pQCT in the tibia and radius, a significant difference in cortical pore diameter at the radius was observed, with higher values in the FPL group. A comparison between the FPL subgroup with DM and the controls confirmed the difference in porosity diameter and showed a statistical difference in the radius trabecular thickness parameter (Tb.Th), with greater Tb.Th in the FPL group with DM. Two patients presented femur fracture after falling from their own height during the study - after 20 years of diagnosis of DM and additional risk factors for frailty. Conclusion: In summary, FPL patients - especially those with DM - exhibit alterations in bone microarchitecture, including increased cortical pore diameter and trabecular thickness. Despite normal or even elevated Z-scores on DXA, fragility fractures may occur, warranting routine imaging and preventive strategies in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.